SUBMISSION DEADLINE EXTENDED THROUGH MONDAY, OCTOBER 19!
Amgen is thrilled to accept submissions for the 2020 Amgen-LabCentral Golden Ticket competition! As a platinum sponsor of LabCentral, Amgen will award two promising start-up companies with a year of lab space, mentorship, and access to Amgen’s expertise across our network at the Cambridge-based life sciences launchpad.
An Amgen-LabCentral Golden Ticket in hand will:
Amgen’s therapeutic focus includes cardiovascular and metabolic diseases, oncology, and inflammation. All companies with innovative advancements in these areas are encouraged to apply, as well as are those focused on making groundbreaking advancements in AI, data science, and manufacturing innovation.
To apply, upload a non-confidential slide deck detailing the following:
Now Extended! Submissions are due by Monday, October 19, 2020 at 11:59 PM EDT
Once submitted, your company’s proposal will be reviewed by an internal committee of Amgen scientists, and five finalists will be identified and notified in mid-November. Finalists will be invited to pitch their company to an expert panel of Amgen scientists and business development leaders virtually in early December. The 2020 awardees will be announced in mid-December.
Questions? Contact us at GoldenTicket@amgen.com.
For additional ways to engage with Amgen, visit www.amgenbd.com/